Healio’s most-viewed psychiatry stories in February highlight a study on antidepressant combination therapies, updates in ADHD treatments and the pandemic’s impact on those with mood and anxiety disorders.
Combination therapy that included an antagonist of presynaptic alpha2-autoreceptors appeared effective and safe for patients with depression who did not respond to monotherapy, according to a report published in JAMA Psychiatry. Read more.
The FDA has granted approval to late-stage biotech company Neurocentria Inc. to conduct a pivotal phase 2b/3 human clinical trial of its drug